Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001628280-21-011233
Filing Date
2021-05-27
Accepted
2021-05-27 17:28:46
Documents
12
Period of Report
2021-03-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A sgmo-20210311.htm   iXBRL 8-K/A 41646
  Complete submission text file 0001628280-21-011233.txt   180117

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20210311.xsd EX-101.SCH 1953
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20210311_lab.xml EX-101.LAB 24270
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20210311_pre.xml EX-101.PRE 12683
5 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20210311_htm.xml XML 11252
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-30171 | Film No.: 21974374
SIC: 2836 Biological Products, (No Diagnostic Substances)